Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis-Reference-Cited by-同舟云学术

Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis

Published:2018-08-02 Issue:8 Volume:79 Page:460-464
ISSN:1750-8460
Container-title:British Journal of Hospital Medicine
language:en
Short-container-title:Br J Hosp Med

Author:

Chapman Roger W¹

Affiliation:

1. Emeritus Consultant in Hepatology, Nuffield Department of Medicine, Oxford University and Translational Gastroenterology Unit, Oxford University Hospital, Oxford OX3 9DU

Publisher

Mark Allen Group

Subject

General Medicine

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2018.79.8.460

Reference21 articles.

1. The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies

2. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’

3. New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

4. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

5. Geotherapeutics of primary biliary cirrhosis: Bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effect of Ursodeoxycholic Acid in Experimental Endometriosis Induced Rat Model;Clinical and Experimental Obstetrics & Gynecology;2023-11-22

2. Obeticholic acid—a new therapy in PBC and NASH;British Medical Bulletin;2020-03

3. Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends;Clinical Reviews in Allergy & Immunology;2019-11-11

4. Letter to the editor;Gastrointestinal Nursing;2019-07